Entyce for Dogs: How This Appetite Stimulant Works and When Vets Prescribe It
When a sick dog stops eating, the clock starts. Nutritional decline accelerates illness, delays healing, and makes everything harder – for the dog and the owner watching. Entyce is the first FDA-approved oral appetite stimulant specifically designed for dogs, and it works differently from the older off-label options. Here is what owners need to know.
What Is Entyce?
Entyce is the brand name for capromorelin oral solution, a ghrelin receptor agonist developed specifically for dogs by Elanco Animal Health. It received FDA approval for use in dogs to manage anorexia (loss of appetite) and promote weight gain in dogs with conditions causing reduced food intake.
Capromorelin is not a sedative, steroid, or antihistamine – it is a new class of molecule that targets the hunger signaling pathway directly. This makes it more specific and predictable in its appetite-stimulating effect than older off-label alternatives like mirtazapine or cyproheptadine, which were developed for other purposes and have different side effect profiles.
Entyce comes as a flavored oral liquid (30 mg/mL) given by mouth once daily, typically mixed with or poured over food. The bacon-chicken flavor is designed to make dosing easier for both dogs and owners.
How Entyce Works: The Ghrelin Pathway
Beyond appetite stimulation, ghrelin receptor activation also promotes growth hormone release and has some anti-nausea properties. This means Entyce may provide mild additional benefit in dogs whose anorexia is partly driven by nausea – though it is not an antiemetic and should not replace dedicated anti-nausea treatment when vomiting is significant.
When Vets Prescribe Entyce
CKD is the most common long-term indication. Appetite decline is a defining feature of advanced CKD, and maintaining nutrition slows disease progression and supports quality of life.
Cancer cachexia (muscle wasting with weight loss) and chemotherapy-associated anorexia are common indications. Nutrition supports treatment tolerance and immune function.
Cardiac cachexia in advanced heart disease leads to significant muscle loss. Supporting appetite helps maintain lean body mass and functional reserve.
Hepatic disease frequently suppresses appetite through nausea and metabolic changes. Entyce helps maintain hepatic caloric and protein intake critical for liver function.
Dogs recovering from major surgery often have reduced appetite for days to weeks. Early return to eating significantly improves recovery speed and wound healing.
Dogs recovering from hospitalization, severe infections, or acute organ injuries may need temporary appetite support to rebuild nutritional reserves.
Dosing
The approved dose of Entyce is 3 mg/kg once daily by mouth. The oral solution is 30 mg/mL, so the volume given depends on the dog’s weight. It can be given directly by mouth using the supplied dosing syringe, mixed into food, or poured over a small amount of a favorite treat.
Store Entyce at room temperature (59 to 77F / 15 to 25C). Do not refrigerate. Use within 30 days of opening. Shake well before each use.
How Quickly Does It Work?
Entyce is one of the faster-acting veterinary medications. In clinical trials:
- Most dogs showed improved appetite within 24 hours of the first dose
- The effect typically builds over the first 2 to 3 days as the body responds to consistent daily dosing
- Dogs that respond tend to show consistent daily improvement in food intake
- Non-responders usually become apparent within 3 to 5 days
For best results, offer your dog’s meal within 30 to 60 minutes of giving Entyce, when the appetite-stimulating effect is peaking. Some dogs benefit from being offered a highly palatable food during the initial days – a warmed meal, a small amount of low-sodium broth poured over kibble, or a favorite food mixed in. The goal is to get the dog eating again; palatability helps establish the habit during the first days of treatment.
Side Effects
Entyce has a favorable safety profile. The most commonly reported side effects in clinical studies were:
- Vomiting: Mild and usually short-lived. Often reduces after the first few days as the body adjusts.
- Diarrhea: Occasional loose stools, generally mild.
- Increased water consumption (polydipsia): Some dogs drink more water. Monitor and report if excessive.
- Hypersalivation: Increased drooling, particularly shortly after dosing.
- Lethargy: Occasional and usually mild.
Entyce is not recommended for dogs with hypoadrenocorticism (Addison’s disease) or for dogs currently receiving corticosteroids. Capromorelin affects cortisol and ACTH levels, which can complicate the hormonal balance these dogs depend on managing carefully. Dogs with diabetes mellitus should be monitored more closely since capromorelin can transiently increase blood glucose. Always tell your vet your dog’s complete medication and health history before Entyce is prescribed.
Entyce vs. Mirtazapine: Choosing Between Appetite Stimulants
Before Entyce, mirtazapine (an antidepressant with off-label appetite-stimulating properties) was the most commonly used appetite stimulant in dogs. The two drugs differ in important ways:
- Mechanism: Entyce targets the hunger pathway directly via ghrelin receptors. Mirtazapine works through serotonin and noradrenaline pathways – appetite stimulation is a side effect, not the primary mechanism.
- FDA approval: Entyce is FDA-approved for dogs. Mirtazapine is used off-label.
- Dosing frequency: Entyce is once daily. Mirtazapine is typically every 1 to 3 days in dogs depending on the formulation.
- Side effects: Mirtazapine can cause sedation, vocalization, and serotonin-related signs. Entyce’s side effect profile is more GI-focused and generally milder.
- Cost: Mirtazapine as a generic is significantly less expensive. Entyce as a brand-name veterinary product costs more.
For many dogs with chronic conditions, Entyce is now considered the preferred first-line appetite stimulant due to its FDA approval, targeted mechanism, and favorable tolerability. Mirtazapine remains a reasonable option for short-term use or in budget-constrained situations where cost is a factor.
When Appetite Stimulants Are Not the Answer
Entyce treats the symptom of anorexia, not the underlying cause. It should always be used alongside – not instead of – treatment for whatever is making the dog not eat. If the cause of anorexia is uncontrolled pain, severe nausea, a foreign body obstruction, dental disease causing oral pain, or another directly addressable problem, fixing the root cause will be more effective and appropriate than masking the symptom with an appetite stimulant.
Signs that warrant a diagnostic workup before or alongside appetite stimulant use:
- Anorexia of sudden onset with no known underlying chronic disease
- Anorexia accompanied by vomiting, abdominal pain, or distension
- Weight loss that is rapid or disproportionate to reduced intake
- Anorexia not responding to Entyce after 3 to 5 days
Frequently Asked Questions
Eating Is Medicine Too
For a dog managing a chronic illness, maintaining adequate nutrition is not just comfort – it is treatment. Muscle mass supports immune function, organ health, and the ability to tolerate and respond to other medications. When a dog stops eating, everything else becomes harder to manage. Entyce’s role is to keep that nutritional foundation in place while the underlying condition is treated.